- Report
- September 2025
- 250 Pages
Global
From €3961EUR$4,490USD£3,479GBP
- Report
- April 2025
- 175 Pages
Global
From €3961EUR$4,490USD£3,479GBP
- Report
- April 2025
- 175 Pages
Global
From €3961EUR$4,490USD£3,479GBP
- Report
- April 2025
- 175 Pages
Global
From €3961EUR$4,490USD£3,479GBP
- Report
- April 2025
- 175 Pages
Global
From €3961EUR$4,490USD£3,479GBP
- Report
- April 2025
- 175 Pages
Global
From €3961EUR$4,490USD£3,479GBP
- Report
- April 2025
- 175 Pages
Global
From €3961EUR$4,490USD£3,479GBP
- Report
- January 2025
- 175 Pages
Global
From €3961EUR$4,490USD£3,479GBP
- Report
- December 2025
- 371 Pages
Global
From €5160EUR$5,850USD£4,533GBP
- Report
- December 2025
- 280 Pages
Global
From €5160EUR$5,850USD£4,533GBP
- Report
- December 2025
- 379 Pages
Global
From €5160EUR$5,850USD£4,533GBP
- Report
- February 2025
- 185 Pages
Global
From €3969EUR$4,500USD£3,487GBP
- Report
- August 2025
- 150 Pages
Global
From €3396EUR$3,850USD£2,983GBP
- Report
- July 2025
- 150 Pages
Global
From €3396EUR$3,850USD£2,983GBP
€4278EUR$4,850USD£3,758GBP
- Report
- June 2025
- 150 Pages
Global
From €2381EUR$2,699USD£2,091GBP
- Report
- June 2025
- 200 Pages
Global
From €2460EUR$2,789USD£2,161GBP
- Report
- May 2025
- 134 Pages
Global
From €15873EUR$17,995USD£13,945GBP
- Report
- December 2024
- 59 Pages
Global
From €3524EUR$3,995USD£3,096GBP
- Report
- January 2025
- 95 Pages
Global
From €3500EUR$4,251USD£3,182GBP
- Report
- December 2025
- 50 Pages
Global
From €2338EUR$2,650USD£2,054GBP

The HIV/AIDS Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs to treat HIV/AIDS. These drugs are used to treat the virus itself, as well as the symptoms and complications associated with it. HIV/AIDS drugs are typically divided into two categories: antiretroviral drugs, which are used to suppress the virus, and prophylactic drugs, which are used to prevent the transmission of the virus.
The HIV/AIDS Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Gilead Sciences, Merck, GlaxoSmithKline, Bristol-Myers Squibb, and Pfizer. These companies are constantly developing new drugs and treatments to improve the quality of life for those living with HIV/AIDS. Show Less Read more